Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome

NCT02295475 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Antiphospholipid Syndrome
Thrombosis

Interventions

DRUG: Apixaban
DRUG: Warfarin

Sponsor

Scott C. Woller, MD

Collaborators

[object Object]
[object Object]